A spondylitis (AS) can be considered as a ies in particular having a pathogenic role, as their titre correlates with disease activity [13, 21] . reactive arthritis following Klebsiella pneumoniae infection in HLA-B27-positive patients, based on consistent
In order to clarify this further, antibody responses to seven K. pneumoniae serotypes have been studied in findings of raised anti-Klebsiella antibodies [1] [2] [3] and the presence of molecular mimicry between the HLApatients with chronic bowel inflammation and AS, and compared to healthy controls. B27 molecule and bacterial antigens [4] [5] [6] . Ileocolonoscopic studies show that bowel inflammation MATERIALS AND METHODS occurs in up to two-thirds of spondyloarthropathy
Patients and controls patients during active phases of the disease [7] [8] [9] [10] .
Sera were collected from five patient groups: AS, Antibodies to various microbes of the gut bacterial Crohn's disease (CD), ulcerative colitis ( UC ), coeliac flora have been found in inflammatory bowel disease disease and normal blood donors. Forty unrelated (IBD), including K. pneumoniae spp. [11] [12] [13] , and HLA-B27-positive AS patients (New York criteria) bacterial antigens and complexes of cell wall compon- [22] , with active disease and an erythrocyte sedimentaents have been detected in areas of inflammation tion rate ( ESR) >15 mm/h, were obtained from the beneath ulcers and fissures [14, 15] . Exposure of the AS Research Clinic at the Middlesex Hospital, mucosal immune system to bacterial antigens is likely London. The IBD groups were obtained from the to promote an inflammatory response [16] [17] [18] with the Department of Gastroenterology, Royal Free Hospital, production of antibodies against K. pneumoniae which London. Forty-six unrelated patients had CD. Active may lead to AS in the genetically predisposed HLAdisease was defined by physician's assessment with B27-positive individual. We have previously shown raised C-reactive protein (CRP) and/or a Harveythat our population of AS and IBD patients have Bradshaw score >4 [23] (19 active). Twenty-three had elevated total antibody titres to K. pneumoniae, but terminal ileal and colonic disease, 10 had colonic not to Eubacterium, Bacteroides, Peptostreptococcus, disease alone and 13 had disease limited to the small Escherichia coli or Proteus mirabilis [19] . It has been bowel. Thirty-eight unrelated patients had UC. Active suggested that immune responses to K. pneumoniae disease was based on physician's assessment with serotypes K26, K36 and K50 are of importance in accompanying raised ESR, or a simple colitis activity HLA-B27-positive AS patients [20] Gastroenterology Unit, UMDS St Thomas' Hospital, London. Nineteen patients had newly diagnosed dis-13 g/l ), were set up by inoculating with two loopfuls of bacteria from the nutrient agar slopes. The cultures ease, seven patients were undergoing gluten challenge and 24 patients had active disease while on treatment.
were incubated at 37°C for 7 h on an orbital shaker, after which 200 ml of nutrient broth in 2 l flasks were Forty-nine patients had positive anti-endomysial antibodies, demonstrated by immunohistochemistry on inoculated with 10 ml of the corresponding cultures and left shaking at 37°C for 16 h. The bacterial cultures human umbilical cord [27] . Forty healthy control sera were supplied by the Blood Transfusion Service, were harvested by centrifugation at 6000 r.p.m. (MSE High Speed18, 6 × 250 ml rotor) for 20 min, washed London ( Table I ) The capsular polysaccharide of K. pneumoniae was type used was isolated from the faecal sample of a CD patient. We selected the three most frequent serotypes extracted as described by Sahly et al. [20] . Klebsiella pneumoniae isolates of capsular types K2, K3, K17, found in the UK, K2, K3 and K21, which are commonly isolated from blood/throat, urine and faeces, K21, K26, K36 and K50 were grown on WorfelFerguson agar [30] at 37°C for 24 h, followed by respectively [28] , and K26, K36 and K50 serotypes which had been reported to evoke higher antibody another 24 h at room temperature to increase capsule production. Using a sterile, disposable cell scraper levels in HLA-B27-positive AS patients compared with other K. pneumoniae capsular serotypes [20] .
(Bibby Sterilin Ltd, Staffordshire), the bacterial lawns were suspended in 10 ml of 0.9% NaCl in a conical flask containing 0.2 mm glass beads. The bacterial
Isolation of K. pneumoniae
Faecal samples were collected from six CD and three suspensions were shaken vigorously for 7 min to detach the capsular polysaccharides, on an orbital shaker, UC patients, attending the Royal Free Hospital, London. A loopful of test material was streaked across glass beads removed and further centrifuged at 4°C for 20 min at 6500 r.p.m. . plates of nutrient agar ( Unipath Ltd, Hampshire) to which had been added 1% w/v inositol, 0.3% v/v of Supernatants were filtered using a membrane with a porosity of 0.22 mm (Millipore, Hertfordshire). The 1% bromothymol blue, 1% w/v Lab lemco and 1% bacteriological peptone. The plates were incubated for filtrate was lyophilized for each of the capsular serotypes and the resulting lyophilizates were dissolved in 18 h at 37°C.
Inositol-fermenting colonies were identified using the 1 ml of distilled water. Total carbohydrate content was determined by the phenol-sulphuric acid method [31] . biochemical API20E kit (Biomérieux, Hampshire) as K. pneumoniae spp. Three K. pneumoniae isolates from
The capsular polysaccharide preparations were diluted in carbonate buffer (0.05 , pH 9.6), giving a final individual CD patients were kindly serotyped by Dr T. Pitt (Central Public Health Laboratory, Colindale).
concentration of 2 mg of carbohydrate/ml. Two positive inositol-fermenting colonies could not be identified further. The third was identified as K. pneuEnzyme-linked immunosorbent assay (ELISA) Ninety-six-well, flat-bottomed, rigid polystyrene moniae serotype K17 and was isolated from a 24-yrold patient with CD having inactive disease, who microtitre plates (Dynatech, Billinghurst) were coated with 200 ml of bacteria or capsular extract in carbonate previously had a resection of both sigmoid colon and terminal ileum, and was taking 5-ASA. buffer (0.05 , pH 9.6), overnight at 4°C. The plates were then washed three times with PBS (pH 7.4), 300 ml of blocking solution were added to each well Preparation of whole bacteria
The individual K. pneumoniae serotypes were grown [0.1% (w/v) bovine serum albumin (BSA), 0.05% (v/v) Tween 20] in PBS and incubated for 1 h at 37°C. in batch culture as described previously [29] . Starter cultures containing 20 ml of nutrient broth ( Unipath Excess blocking solution was removed and 200 ml serum samples, test or control, diluted 1/200 in PBSTween were added in duplicate. Plates were incubated for 2 h at 37°C, followed by the addition of 200 ml of peroxidase-conjugated rabbit anti-human class-specific IgG, IgA or IgM (Dako Ltd, Buckinghamshire) diluted 1/500 in PBS-Tween, and incubated for a further 2 h at 37°C. Development of the colorimetric assay took place at room temperature for 20 min after the addition of 200 ml/well 0.5 g/ml 2,2∞-azinobis(3-ethylbenzthiazoline-6-sulphonic acid) (Sigma, Dorset) in citrate/ phosphate buffer (pH 4.1), containing 0.98 mM H 2 O 2 (Sigma). The reaction was stopped with 100 ml of 2 mg/ml sodium fluoride (Sigma) and ODs measured at a wavelength of 630 nm with a micro-ELISA plate reader (Dynatech MR600). All assays were carried out under code, in that the tester did not know whether a sample was a test or control serum.
C-Reactive protein determination
CRP levels were determined by the single radial immunodiffusion method of Mancini et al. [32] and the results expressed in mg/l of serum.
Statistical analysis
Differences in immunoglobulin class levels against the various K. pneumoniae isolates in the serum samples of patients and those classified according to disease site were assessed by comparing the proportion in each group having OD units greater than the 95% confidence limits for the population of controls (one-tailed test) using the x2 test, with Yates correction (significance was taken at P < 0.05). The reproducibility of the assay was tested by calculating the coefficient of variation.
RESULTS

Antibodies to whole bacteria
Levels of IgG, IgA and IgM antibodies to each of the seven different K. pneumoniae serotypes were meas- tailed test) were determined. pneumoniae serotypes K2, K3, K17, K21, K26, K36 and K50. An A significant percentage of AS patients showed asterisk indicates statistical significance compared to the healthy raised IgG levels to whole K. pneumoniae spp. K17 control group; *P < 0.05, **P < 0.01, ***P < 0.001 using x2 test (x2 = 5.60, P < 0.05), K36 (x2 = 13.20, P < 0.001) with Yates correction. and K50 (x2 = 4.24, P < 0.05) compared with the healthy control population (Fig. 1A) . Furthermore, IgA antibody levels to K21 (x2 = 7.58, P < 0.01), K26 in a greater proportion of patients above the 95% limit to K2 (x2 = 4.23, P < 0.05), K21 (x2 = 12.24, (x2 = 4.78, P < 0.05), K36 (x2 = 6.33, P < 0.05), K50 (x2 = 12.11, P < 0.001) (Fig. 1B) and of IgM to K21 P < 0.001), K26 (x2 = 13.01, P < 0.001), K36 (x2 = 15.23, P < 0.001) and K50 (x2 = 22.10, (x2 = 2.85, P < 0.05) were also found to be elevated in a greater number of AS patients when compared P < 0.001) (Fig. 1B) . When measuring IgM antibody levels, a significant response was seen using K21 with controls (Fig. 1C ) .
In a significant percentage of CD patients, IgG (x2 = 7.01, P < 0.01) and K50 (x2 = 11.40, P < 0.001) (Fig. 1C ) . antibody levels were raised to K17 (x2 = 23.44, P < 0.001), K26 (x2 = 8.16, P < 0.01), K36 No significant differences in mean antibody levels to any of the K. pneumoniae spp. tested were found when (x2 = 21.92, P < 0.001) and K50 (x2 = 13.93, P < 0.001) when compared with controls ( Fig. 1A) . A either CD or UC patients were divided into clinically active and inactive groups. Furthermore, there was no similar IgA response was detected in both CD and AS patients. The IgA antibody level was found to be raised significant difference in the number of both CD and UC patients with antibody levels above the confidence limits when patients were classified according to disease site ( Table II ) . A proportion of patients with UC exhibited elevated IgG antibody levels to K. pneumoniae spp. K17 (x2 = 4.51, P < 0.05), K36 (x2 = 9.19, P < 0.01) and K50 (x2 = 5.25, P < 0.05) (Fig. 1A) . Two UC patients with AS and who were also HLA-B27 positive had IgG, IgA and IgM antibody levels above the confidence limit to the whole bacteria K2, K3, K17 and K50, and antibodies to capsular extracts of K2, K3, K21, K26 and K50. Both were male; one had disease limited to the left colon, and the second had total colitis. Both had active disease requiring steroid therapy at the time of sampling. One male UC patient with AS who was HLA-B27 negative with total extensive active disease had increased IgG and IgA immunoglobulin levels above the 95% limit to K36 and K50 only. Patients with coeliac disease did not have any antibody class levels elevated above the confidence limits to any of the K. pneumoniae spp. tested.
The mean coefficient of variation for IgG bacterial serotype assays was 3.9% (range 2.7-6.9%), for IgA 
-Percentage of ankylosing spondylitis, Crohn's disease, 3/20g --ulcerative colitis and coeliac disease patients with antibodies ( ELISA OD 630 nm) IgG (A), IgA (B) and IgM (C ) elevated above the 95% K21 CD -12/23a 6/23a -6 /10b 2/10b confidence limit of controls to capsular extracts of K. pneumoniae -6 /13c 6/13c serotypes K2, K3, K17, K21, K26, K36 and K50. An asterisk indicates statistical significance compared to the healthy control K26 CD 10/23a 11/23a -group; *P < 0.05, **P < 0.01, ***P < 0.001 using x2 (x2 = 3.80, P < 0.05) were found to be raised in a significant percentage of AS patients (Fig. 2A) ; IgA
--antibody levels were elevated to K2 (x2 = 11.96, 5/20g --P < 0.001), K3 (x2 = 17.20, P < 0.001), K21 (x2 = 3.79, P < 0.05), K26 (x2 = 8.06, P < 0.01) and a, terminal ileal and colonic disease; b, colonic disease alone;
K36 (x2 = 6.33, P < 0.05) extracts (Fig. 2B) , but no c, small bowel disease only; e, total/extensive disease; f, proctitis alone; g, left-sided disease.
increased IgM antibody elevation to any capsular extract was detected in AS patients when compared to to healthy controls, and there was no statistical difference in the number of UC patients who showed raised healthy controls (Fig. 2C ) .
A significant number of CD patients showed IgG antibodies above the confidence limits when classified according to disease site. increased IgG antibody levels to capsular extracts of K2 (x2 = 12.69, P < 0.001), K21 (x2 = 7.14,
The mean coefficient of variation value for the capsular IgG assays was 4.8% (range 4.2-5.4%), for P < 0.01), K26 (x2 = 10.33, P < 0.01), K36 (x2 = 8.04, P < 0.01) and K50 (x2 = 7.39, P < 0.01) IgA assays 6.6% (range 5.4-8.0%) and for IgM assays 3.9% (range 2.3-6.9%). in comparison with the controls (Fig. 2A) , whilst IgA antibodies were detected to the same K. pneumoniae DISCUSSION extracts as those found to be elevated in AS patients: K2 (x2 = 18.48, P < 0.001), K3 (x2 = 25.86, This study confirms that both AS and CD patients have elevated levels of IgG, IgA and IgM antibodies P < 0.001), K21 (x2 = 6.04, P < 0.01), K26 (x2 = 10.61, P < 0.001) and K36 (x2 = 11.48, to K. pneumoniae, whilst UC patients had elevated IgG only. The immune responses also involve Klebsiella P < 0.001) ( Fig. 2B) . When testing for IgM antibodies, a significant percentage of CD patients had increased bacteria having capsular serotypes other than K26, K36 and K50. The capsular serotypes of K. pneumoniae levels to K2 (x2 = 3.56, P < 0.05), K3 (x2 = 3.57, P < 0.05), K17 (x2 = 3.82, P < 0.05) and K50 vary in their pathogenicity. Sahly et al. [20] undertook an extensive investigation of the role of all 77 capsular (x2 = 6.04, P < 0.05) extracts compared to controls ( Fig. 2C ) .
serotypes in the immune responses of AS patients, comparing them with reactive arthritis following There was no significant difference between mean antibody levels to the K. pneumoniae capsular extracts Yersinia infection, rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus patients and normal in CD and UC patients when divided according to disease activity. Furthermore, there was no significant controls. They found that the sera from HLA-B27-positive AS patients had significantly higher levels difference in the number of CD patients having antibody class levels above the confidence limit to of IgG antibodies to the capsular serotypes K26, K36 and K50 compared to all other groups, suggesting a K. pneumoniae extracts when classified according to disease site ( Table III ) . In addition, no antibody class pre-eminent role for these microbes.
We have shown that a certain percentage of AS levels were elevated in the UC or coeliac disease groups to any of the capsular extracts tested when compared patients in our populations have significant IgG antibody responses to the capsular extract of K36 and to the whole bacteria of K17, K36 and K50. IgA antibod- number of both whole and capsular extracts of Klebsiella serotypes tested compared to the UC patient a, terminal ileal and colonic disease; b, colonic disease alone; c, small bowel disease only.
with AS who was HLA-B27 negative. The CD patients
